Welcure Drugs & Pharmaceuticals Discontinues Corporate Office Located in Ahmedabad
Welcure Drugs & Pharmaceuticals Ltd has taken an administrative decision regarding one of its office locations, announcing that the corporate office situated in Ahmedabad will be discontinued effective July 14, 2026.The Board of Directors announced the closure of the specific corporate office location, which is set up at 608 6th Floor Shree Balaji Heights, Nr Bodyline Cross Road C G Road, Ellisbridge, Ahmedabad, Ahmadabad City, Gujarat, India, 380006. This decision was made as part of a broader strategy for operational efficiency and resource optimization within the company, according to the Board’s notes.
The company confirmed that despite the closure of the corporate office, all business operations will continue without any interruption. The meeting of the Board of Directors considered and approved this change.
Following the discontinuation of the Ahmedabad location, the management has stipulated that all statutory records, including the Books of Account and other statutory registers previously maintained at the closed Corporate Office, will be transferred. These records will subsequently be maintained at the Registered Office of Welcure Drugs & Pharmaceuticals Ltd in accordance with applicable regulations.
Stock Price Movement
Welcure Drugs & Pharmaceuticals Ltd shares settled at ₹0.26 at the close of trade today, climbing 4.00%. The stock experienced intraday volatility, trading within a range that stretched from a low of ₹0.24 to a high of ₹0.27.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.